These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 8079372)

  • 1. In vitro neutralization of the inhibitory effect of Microcystin-LR to protein phosphatase 2A by antibody against the toxin.
    Lin JR; Chu FS
    Toxicon; 1994 May; 32(5):605-13. PubMed ID: 8079372
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of natural toxins with inhibitory activity against serine/threonine protein phosphatases.
    Honkanen RE; Codispoti BA; Tse K; Boynton AL; Honkanan RE
    Toxicon; 1994 Mar; 32(3):339-50. PubMed ID: 8016855
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of an archaeal protein phosphatase activity by okadaic acid, microcystin-LR, or calyculin A.
    Oxenrider KA; Rasche ME; Thorsteinsson MV; Kennelly PJ
    FEBS Lett; 1993 Oct; 331(3):291-5. PubMed ID: 8397116
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cyanobacterial microcystin-LR is a potent and specific inhibitor of protein phosphatases 1 and 2A from both mammals and higher plants.
    MacKintosh C; Beattie KA; Klumpp S; Cohen P; Codd GA
    FEBS Lett; 1990 May; 264(2):187-92. PubMed ID: 2162782
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Parallel purification of three catalytic subunits of the protein serine/threonine phosphatase 2A family (PP2A(C), PP4(C), and PP6(C)) and analysis of the interaction of PP2A(C) with alpha4 protein.
    Kloeker S; Reed R; McConnell JL; Chang D; Tran K; Westphal RS; Law BK; Colbran RJ; Kamoun M; Campbell KS; Wadzinski BE
    Protein Expr Purif; 2003 Sep; 31(1):19-33. PubMed ID: 12963337
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prolonged sublethal exposure to the protein phosphatase inhibitor microcystin-LR results in multiple dose-dependent hepatotoxic effects.
    Solter PF; Wollenberg GK; Huang X; Chu FS; Runnegar MT
    Toxicol Sci; 1998 Jul; 44(1):87-96. PubMed ID: 9720145
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of specific binding of okadaic acid to protein phosphatase 2A by microcystin-LR, calyculin-A and tautomycin: method of analysis of interactions of tight-binding ligands with target protein.
    Takai A; Sasaki K; Nagai H; Mieskes G; Isobe M; Isono K; Yasumoto T
    Biochem J; 1995 Mar; 306 ( Pt 3)(Pt 3):657-65. PubMed ID: 7702557
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vivo and in vitro binding of microcystin to protein phosphatases 1 and 2A.
    Runnegar M; Berndt N; Kong SM; Lee EY; Zhang L
    Biochem Biophys Res Commun; 1995 Nov; 216(1):162-9. PubMed ID: 7488083
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Microcystin-LR and okadaic acid-induced cellular effects: a dualistic response.
    Gehringer MM
    FEBS Lett; 2004 Jan; 557(1-3):1-8. PubMed ID: 14741332
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Okadaic acid and microcystin-LR directly inhibit the methylation of protein phosphatase 2A by its specific methyltransferase.
    Li M; Damuni Z
    Biochem Biophys Res Commun; 1994 Jul; 202(2):1023-30. PubMed ID: 8048914
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatocyte DNA replication is abolished by inhibitors selecting protein phosphatase 2A rather than phosphatase 1.
    Mellgren G; Vintermyr OK; Bøe R; Døskeland SO
    Exp Cell Res; 1993 Apr; 205(2):293-301. PubMed ID: 8387016
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of microcystin-LR, a potent inhibitor of type 1 and type 2A protein phosphatases.
    Honkanen RE; Zwiller J; Moore RE; Daily SL; Khatra BS; Dukelow M; Boynton AL
    J Biol Chem; 1990 Nov; 265(32):19401-4. PubMed ID: 2174036
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A molecular basis for different interactions of marine toxins with protein phosphatase-1. Molecular models for bound motuporin, microcystins, okadaic acid, and calyculin A.
    Bagu JR; Sykes BD; Craig MM; Holmes CF
    J Biol Chem; 1997 Feb; 272(8):5087-97. PubMed ID: 9030574
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protein phosphatase inhibition and in vivo hepatotoxicity of microcystins.
    Runnegar MT; Kong S; Berndt N
    Am J Physiol; 1993 Aug; 265(2 Pt 1):G224-30. PubMed ID: 8396333
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential toxicity of the protein phosphatase inhibitors microcystin and calyculin A.
    Runnegar MT; Maddatu T; Deleve LD; Berndt N; Govindarajan S
    J Pharmacol Exp Ther; 1995 Apr; 273(1):545-53. PubMed ID: 7714810
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Removal of phosphate from phosphohistidine in proteins.
    Kim Y; Pesis KH; Matthews HR
    Biochim Biophys Acta; 1995 Aug; 1268(2):221-8. PubMed ID: 7662712
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Monitoring of microcystin-protein phosphatase adduct formation with immunochemical methods.
    Liu BH; Yu FY; Huang X; Chu FS
    Toxicon; 2000 May; 38(5):619-32. PubMed ID: 10673155
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sucrose-phosphate synthase is dephosphorylated by protein phosphatase 2A in spinach leaves. Evidence from the effects of okadaic acid and microcystin.
    Siegl G; MacKintosh C; Stitt M
    FEBS Lett; 1990 Sep; 270(1-2):198-202. PubMed ID: 2171989
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Microcystin uptake and inhibition of protein phosphatases: effects of chemoprotectants and self-inhibition in relation to known hepatic transporters.
    Runnegar M; Berndt N; Kaplowitz N
    Toxicol Appl Pharmacol; 1995 Oct; 134(2):264-72. PubMed ID: 7570603
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of serine/threonine protein phosphatases in RINm5F insulinoma cells.
    Sjöholm A; Honkanen RE; Berggren PO
    Biosci Rep; 1993 Dec; 13(6):349-58. PubMed ID: 8204804
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.